BioTuesdays

Tag - Alliance Global Partners

MeaTech Logo

AGP starts MeaTech at buy; PT $11

Alliance Global Partners initiated coverage of MeaTech 3D (NASDAQ:MITC) with a “buy” rating and $11 price target. The stock closed at $3.55 on July 15. MeaTech is a cellular agriculture firm focused on developing human...

OpGen Logo

AGP cuts OpGen to neutral; PT to 67 cents

Alliance Global Partners downgraded OpGen (NASDAQ:OPGN) to “neutral” and lowered its price target to 67 cents, citing the company’s cash needs. The stock closed at 61 cents on July 11. “We view the company’s...

T2 Biosystems Logo

AGP cuts T2 Biosystems to neural; PT to 14 cents

Alliance Global Partners downgraded T2 Biosystems (NASDAQ:TTOO) to “neutral” from “buy” and reduced its price target to 14 cents from 65 cents, citing a fiscal second quarter preliminary revenue miss. The stock was...

Reshape-Lifesciences-Logo

AGP cuts ReShape Lifesciences PT to $5.50 from $10.25

Alliance Global Partners slashed its price target for ReShape Lifesciences (NASDAQ:RSLS) to $5.50 from $10.25 but maintained its “buy” rating, citing the company’s fourth quarter results. The stock closed at $1.35 on...

NeuroOne

AGP starts NeuroOne Medical at buy; PT $5.75

Alliance Global Partners launched coverage of NeuroOne Medical Technologies (NASDAQ:NMTC) with a “buy” rating and price target of $5.75. The stock closed at $2.09 on Dec. 2. NeuroOne’s flexible, thin-film...

T2 Biosystems Logo

AGP cuts T2 Biosystems PT to 88 cents from $1.25

Alliance Global Partners reduced its price target for T2 Biosystems (NASDAQ:TTOO) to 88 cents from $1.25 and maintained a “neutral” rating after the company reported mixed third quarter results. The stock closed at 79...

Agrify

AGP starts Agrify at buy; PT $32

Alliance Global Partners initiated coverage of Agrify (NASDAQ:AGFY) with a “buy” rating and $32 price target. The stock closed at $16 on Oct. 29. “We see Agrify as an ancillary play on cannabis with the company’s...

IceCure New

AGP starts IceCure Medical at buy; PT $14.50

Alliance Global Partners launched coverage of IceCure Medical (NASDAQ:ICCM) with a “buy” rating and price target of $14.50. The stock closed at $8.61 on Sept. 21. IceCure has developed and markets the IceCure family of...

Greenlane

AGP starts Greenlane at buy; PT $6

Alliance Global Partners initiated coverage of Greenlane Holdings (NASDAQ:GNLN) with a “buy” rating and $6 price target. The stock closed at $2.73 on Sept. 3. Analyst Aaron Grey writes that Greenlane is now positioned...